Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Treatments for hair loss vary, but cell-based options may be the future.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Teak leaf extract can help treat hair loss, and its effectiveness varies by geographic origin.

MK-386 reduces sebum DHT levels.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Photobiomodulation helps hair regrow in injured skin by aiding cell movement and secretion.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Escitalopram helped a woman with hair-pulling due to long COVID.

Neurosteroids help control dopamine responses in the brain.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.